Horizon Therapeutics Public Limited Company is a company in the U.S. stock market and it is a holding in 70 U.S.-traded ETFs. HZNP has around 10.2M shares in the U.S. ETF market. The largest ETF holder of HZNP is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 1.76M shares. Investors may also find of interest that the ETF with the largest allocation to HZNP stock is SPDR S&P Pharmaceuticals ETF (XPH), with a portfolio weight of 5.04%. On average, U.S. ETFs allocate 0.39% of HZNP to their portfolios.
Additionally, HZNP is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with HZNP as a holding is the iShares Russell Mid-Cap Growth ETF (IWP), with a return of 5.14%.